3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroendocrine Tumors
12
Meningioma
5
Prostatic Neoplasms
2
Pheochromocytoma
2
Paraganglioma
2
Neuroblastoma
2
Medulloblastoma
2
Glioma
2
Glioblastoma
2
Ependymoma
2
Carcinoma, Merkel Cell
2
Sarcoma, Synovial
1
Recurrence
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neoplasms, Germ Cell and Embryonal
1
Metastatic Digestive System Neuroendocrine Tumor G1
1
Hypertension
1
Gastro-enteropancreatic neuroendocrine tumor
1
Extensive Stage Small Cell Lung Cancer
1
Esthesioneuroblastoma, Olfactory
1
Disease Progression
1
Diffuse Intrinsic Pontine Glioma
1
Central Nervous System Neoplasms
1
Carcinoma
1
Carcinoid Tumor
1
Advanced Lung Neuroendocrine Tumor
1
Adrenal Gland Neoplasms
1
Adrenal Cortex Neoplasms
1
Adenoma, Islet Cell
1
Interventions
Oxaliplatin
29
Fluorouracil
23
Capecitabine
19
pembrolizumab
17
Nivolumab
17
Leucovorin
16
Docetaxel
10
Paclitaxel
9
Drug Therapy
9
Cisplatin
9
fludarabine
8
Trastuzumab
8
S 1 (combination)
8
Cyclophosphamide
8
Specimen Handling
7
trastuzumab deruxtecan
6
Bevacizumab
6
Magnetic Resonance Spectroscopy
5
Biopsy
5
zolbetuximab
4
Irinotecan
4
Carboplatin
4
zimberelimab
3
sintilimab
3
olaparib
3
fludarabine phosphate
3
durvalumab
3
atezolizumab
3
aldesleukin
3
XELOX
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
lutetium Lu 177 dotatate
×
90 days
×
Clear all
No trials found.